Biological characterization of Rev variation in equine infectious anemia virus

Journal of Virology

Volumn 72, Issue 5, 1998, Pages 4421-4426

  Belshan, Michael ^a   Harris, Matthew E ^b   Shoemaker, Anne E ^a   Hope, Thomas J ^b   Carpenter, Susan ^a  

^a IOWA STATE UNIVERSITY   (United States)

^b SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

REV PROTEIN;

ARTICLE; EQUINE INFECTIOUS ANEMIA VIRUS; NONHUMAN; PRIORITY JOURNAL; RNA SPLICING; SEQUENCE ANALYSIS; VIRUS GENE; VIRUS REPLICATION;

EID: 0031968989     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.5.4421-4426.1998     Document Type: Article

References (42)

1. Alexandersen, S., and S. Carpenter. 1991. Characterization of variable regions in the envelope and S3 open reading frame of equine infectious anemia virus. J. Virol. 65:4255-4262.
2. Bogerd, H., and W. C. Greene. 1993. Dominant negative mutants of human T-cell leukemia virus type I Rex and human immunodeficiency virus type 1 Rev fail to multimerize in vivo. J. Virol. 67:2496-2502.
3. Carpenter, S., and S. Alexandersen. 1992. Pathogenesis of equine infectious anemia virus infection. Semin. Virol. 3:157-166.
4. Carpenter, S., S. Alexandersen, M. J. Long, S. Perryman, and B. Chesebro. 1991. Identification of a hypervariable region in the long terminal repeat of equine infectious anemia virus. J. Virol. 65:1605-1610.
5. Carpenter, S., and B. Chesebro. 1989. Change in host cell tropism associated with in vitro replication of equine infectious anemia virus. J. Virol. 63:2492-2496.
6. Carpenter, S., L. H. Evans, M. Sevoian, and B. Chesebro. 1987. Role of the host immune response in selection of equine infectious anemia virus variants. J. Virol. 61:3783-3789.
7. Carroll, R., and D. Derse. 1993. Translation of equine infectious anemia virus bicistronic tat-rev mRNA requires leaky ribosome scanning of the tat CTG initiation codon. J. Virol. 67:1433-1440.
8. Cochrane, A. W., C.-H. Chen, and C. A. Rosen. 1990. Specific interaction of the human immunodeficiency virus rev protein with a structured region in the env mRNA. Proc. Natl. Acad. Sci. USA 87:1198-1202.
9. Cullen, B. R. 1992. Mechanism of action of regulatory proteins encoded by complex retroviruses. Microbiol. Rev. 56:375-394.
10. Fischer, U., J. Huber, W. C. Boelens, I. W. Mattal, and R. Luhrmann. 1995. The HIV-1 rev activation domain is a nuclear export signal that accesses an export pathway used by specific cellular RNAs. Cell 82:475-483.
11. Fridell, R. A., H. P. Bogerd, and B. R. Cullen. 1996. Nuclear export of late HIV-1 mRNAs occurs via a cellular protein export pathway. Proc. Natl. Acad. Sci. USA 93:4421-4424.
12. Fridell, R. A., K. M. Partin, S. Carpenter, and B. R. Cullen. 1993. Identification of the activation domain of equine infectious anemia virus Rev. J. Virol. 67:7317-7323.
13. Gontarek, R. R., and D. Derse. 1996. Interactions among SR proteins, an exonic splicing enhancer, and a lentivirus Rev protein regulate alternative splicing. Mol. Cell. Biol. 16:2325-2331.
14. Hammond, S. A., S. J. Cook, D. L. Lichtenstein, C. J. Issel, and R. C. Montelaro. 1997. Maturation of the cellular and humoral immune responses to persistent infection in horses by equine infectious anemia virus is a complex and lengthy process. J. Virol. 71:3840-3852.
15. Harris, M. E., G. J. Smith III, F. J. Kim, and T. J. Hope. 1997. Unpublished data.
16. Hu, J., J. J. Caffrey, and B. R. Cullen. 1996. Functional consequences of natural sequence variation in the activation domain of HIV-1 Rev. Virology 222:423-429.
17. Huang, X., T. J. Hope, B. L. Bond, D. McDonald, K. Grahl, and T. G. Parslow. 1991. Minimal Rev-response element for type 1 human immunodeficiency virus. J. Virol. 45:2131-2134.
18. Iversen, A. K. N., E. G. Shpaer, A. G. Rodrigo, M. S. Hirsch, B. D. Walker, H. W. Sheppard, T. C. Merigan, and J. I. Mullins. 1995 Persistence of attenuated rev genes in a human immunodeficiency virus type 1-infected asymptomatic individual. J. Virol. 69:5743-5753.
19. Kawakami, T., L. Sherman, J. Dahlbert, A. Gazit, A. Yaniv, S. R. Tronick, and S. A. Aaronson. 1987. Nucleotide sequence analysis of equine infectious anemia proviral DNA. Virology 158:300-312.
20. Kono, Y. 1972. Recurrences of equine infectious anemia, p. 175-186. In J. T. Bryans and H. Gerber. (ed.), Proceedings of the Conference on Equine Infectious Diseases. S. Karger, Basel, Switzerland.
21. Leroux, C., C. J. Issel, and R. C. Montelaro. 1997. Novel and dynamic evolution of equine infectious anemia virus genomic quasispecies associated with sequential disease cycles in an experimentally infected pony. J. Virol. 71:9627-9639.
22. Madore, S. J., L. S. Tiley, M. H. Malim, and B. R. Cullen. 1994. Sequence requirements for rev multimerization in vivo. Virology 202:186-194.
23. Malim, M. H., and B. R. Cullen. 1991. HIV-1 structural gene expression requires the binding of multiple Rev monomers to the viral RRE: implications for HIV-1 latency. Cell 65:241-248.
24. Malim, M. H., J. Hauber, S.-Y. Le, J. V. Maizel, and B. R. Cullen. 1989. The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA. Nature 338:254-256.
25. Mancuso, V. A., T. J. Hope, L. Zhu, D. Derse, T. Phillips, and T. G. Parslow. 1994. Posttranscriptional effector domains in the Rev proteins of feline immunodeficiency virus and equine infectious anemia virus. J. Virol. 68: 1998-2001.
26. Martarano, L., R. Stephens, N. Rice, and D. Derse. 1994. Equine infectious anemia virus trans-regulatory protein Rev controls viral mRNA stability, accumulation, and alternative splicing. J. Virol. 68:3102-3111.
27. Maury, W., S. Perryman, J. L. Oaks, B. K. Seid, T. Crawford, T. McGuire, and S. Carpenter. 1997. Localized sequence heterogeneity in the long terminal repeats of in vivo isolates of equine infectious anemia virus. J. Virol. 71:4929-4937.
28. McGuire, T. C., T. B. Crawford, and J. B. Henson. 1971. Immunofluorescent localization of equine infectious anemia virus in tissue. Am. J. Pathol. 62: 283-294.
29. + cytotoxic T lymphocytes from horses with equine infectious anemia virus recognize Env and Gag/PR proteins. J Virol. 68:1459-1467.
30. Meyer, B. E., J. L. Meinkoth, and M. H. Malim. 1996. Nuclear transport of human immunodeficiency virus type 1, visna virus, and equine infectious anemia virus Rev proteins: identification of a family of transferable nuclear export signals. J. Virol. 70:2350-2359.
31. Michael, N. L., L. d'Arcy, P. K. Ehrenberg, and R. R. Redfield. 1994. Naturally occurring genotypes of the human immunodeficiency virus type 1 long terminal repeat display a wide range of basal and Tat-induced transcriptional activities. J. Virol. 68:3163-3174.
32. Montelaro, R. C., B. Parekh, A. Orrego, and C. J. Issel. 1984. Antigenic variation during persistent infection by equine infectious anemia virus, a retrovirus. J. Biol. Chem. 259:10539-10544.
33. Oldstone, M. B. A. 1989. Viral persistence. Cell 56:517-520.
34. Olsen, H., A. Cochrane, P. Dillon, C. Nalin, and C. Rosen. 1990. Interaction of the human immunodeficiency virus type 1 rev protein with a structured region in env mRNA is dependent on multimer formation mediated through a basic stretch of amino acids. Genes Dev. 4:1357-1364.
35. Payne, S. L., F.-D. Fang, C.-P. Liu, B. R. Dhruva, P. Rwambo, C. J. Issel, and R. C. Montelaro. 1987. Antigenic variation and lentivirus persistence: variations in envelope gene sequences during EIAV infection resemble changes reported for sequential isolates of HIV. Virology 161:321-331.
36. Phillips, T. R., C. Lamont, D. A. M. Konings, B. L. Shacklett, C. A. Hamson, P. A. Luciw, and J. H. Elder. 1992. Identification of the Rev transactivation and Rev-responsive elements of feline immunodeficiency virus. J. Virol. 66:5464-5471.
37. Roth, J., and M. Dobbelstein. 1997. Export of hepatitis B virus RNA on a Rev-like pathway: inhibition by the regenerating liver inhibitory factor IκBα. J. Virol. 71:8933-8939.
38. Saltarelli, M. J., R. Schoborg, G. N. Pavlakis, and J. E. Clements. 1994. Identification of the caprine arthritis encephalitis virus rev protein and its cis-acting rev-responsive element. Virology 199:47-55.
39. Stephens, R. M., D. Derse, and N. R. Rice. 1990. Cloning and characterization of cDNAs encoding equine infectious anemia Tat and putative Rev proteins. J. Virol. 64:3716-3725.
40. Stutz, F., M. Neville, and M. Rosbash. 1995. Identification of a novel nuclear pore-associated protein as a functional target of the HIV-1 rev protein in yeast. Cell 82:495-506.
41. Zapp, M., T. Hope, T. Parslow, and M. Green. 1988. Oligomerization and RNA binding domains of the type 1 human immunodeficiency virus rev protein: a dual function for an arginine-rich motif. Proc. Natl. Acad. Sci. USA 88:7734-7738.
42. Zapp, M. L., and M. R. Green. 1989. Sequence-specific RNA binding by the HIV-1 Rev protein. Nature 342:714-716.